Global Gammaretroviral Vector Market Growth 2022-2028
Gammaretroviruses are retroviral vectors in laboratory studies. These vectors are critical for gene therapy and gene transfer. They are so helpful because their genomes are simple and easy to use. Gammaretroviruses have a wide range of implications for animals. They have been linked to various diseases, including cancer, specifically leukemias and lymphomas, neurological diseases, and immunodeficiencies in multiple species. Gammaretroviruses, like other retroviruses, reverse transcribe a positive single strand RNA into double stranded DNA. The double-stranded DNA is highly stable and easily integrated into the host genome. Moloney murine leukaemia virus, xenotropic MuLB-related virus, feline leukaemia virus, and feline sarcoma virus are some examples of the virus.
The global market for Gammaretroviral Vector is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Gammaretroviral Vector market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Gammaretroviral Vector market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Gammaretroviral Vector market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Gammaretroviral Vector market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Gammaretroviral Vector players cover Novasep, MerckKGaA, Charles River Laboratories, UniQure N.V. and Waisman Biomanufacturing, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Gammaretroviral Vector market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Gammaretroviral Vector market, with both quantitative and qualitative data, to help readers understand how the Gammaretroviral Vector market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Gammaretroviral Vector market and forecasts the market size by Type (Lentiviral Vectors, Adenoviral Vectors and Adeno-Associated Viral Vectors), by Application (Gene Therapy, Vaccinology and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Lentiviral Vectors
Adenoviral Vectors
Adeno-Associated Viral Vectors
Other
Segmentation by application
Gene Therapy
Vaccinology
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Novasep
MerckKGaA
Charles River Laboratories
UniQure N.V.
Waisman Biomanufacturing
Creative-Biogene
Aldevron
Addgene
Oxford Biomedica
Thermo Fisher Scientific Inc.
Fujifilm Corporation
Spark Therapeutics Inc
ABL Inc
Boehringer Ingelheim International GmbH
Brammer Bio
Creative Biogene
General Electric
Pfizer Inc
Chapter Introduction
Chapter 1: Scope of Gammaretroviral Vector, Research Methodology, etc.
Chapter 2: Executive Summary, global Gammaretroviral Vector market size (sales and revenue) and CAGR, Gammaretroviral Vector market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Gammaretroviral Vector sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Gammaretroviral Vector sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Gammaretroviral Vector market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Novasep, MerckKGaA, Charles River Laboratories, UniQure N.V., Waisman Biomanufacturing, Creative-Biogene, Aldevron, Addgene and Oxford Biomedica, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gammaretroviral Vector Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Gammaretroviral Vector by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Gammaretroviral Vector by Country/Region, 2017, 2022 & 2028
2.2 Gammaretroviral Vector Segment by Type
2.2.1 Lentiviral Vectors
2.2.2 Adenoviral Vectors
2.2.3 Adeno-Associated Viral Vectors
2.2.4 Other
2.3 Gammaretroviral Vector Sales by Type
2.3.1 Global Gammaretroviral Vector Sales Market Share by Type (2017-2022)
2.3.2 Global Gammaretroviral Vector Revenue and Market Share by Type (2017-2022)
2.3.3 Global Gammaretroviral Vector Sale Price by Type (2017-2022)
2.4 Gammaretroviral Vector Segment by Application
2.4.1 Gene Therapy
2.4.2 Vaccinology
2.4.3 Other
2.5 Gammaretroviral Vector Sales by Application
2.5.1 Global Gammaretroviral Vector Sale Market Share by Application (2017-2022)
2.5.2 Global Gammaretroviral Vector Revenue and Market Share by Application (2017-2022)
2.5.3 Global Gammaretroviral Vector Sale Price by Application (2017-2022)
3 Global Gammaretroviral Vector by Company
3.1 Global Gammaretroviral Vector Breakdown Data by Company
3.1.1 Global Gammaretroviral Vector Annual Sales by Company (2020-2022)
3.1.2 Global Gammaretroviral Vector Sales Market Share by Company (2020-2022)
3.2 Global Gammaretroviral Vector Annual Revenue by Company (2020-2022)
3.2.1 Global Gammaretroviral Vector Revenue by Company (2020-2022)
3.2.2 Global Gammaretroviral Vector Revenue Market Share by Company (2020-2022)
3.3 Global Gammaretroviral Vector Sale Price by Company
3.4 Key Manufacturers Gammaretroviral Vector Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gammaretroviral Vector Product Location Distribution
3.4.2 Players Gammaretroviral Vector Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gammaretroviral Vector by Geographic Region
4.1 World Historic Gammaretroviral Vector Market Size by Geographic Region (2017-2022)
4.1.1 Global Gammaretroviral Vector Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Gammaretroviral Vector Annual Revenue by Geographic Region
4.2 World Historic Gammaretroviral Vector Market Size by Country/Region (2017-2022)
4.2.1 Global Gammaretroviral Vector Annual Sales by Country/Region (2017-2022)
4.2.2 Global Gammaretroviral Vector Annual Revenue by Country/Region
4.3 Americas Gammaretroviral Vector Sales Growth
4.4 APAC Gammaretroviral Vector Sales Growth
4.5 Europe Gammaretroviral Vector Sales Growth
4.6 Middle East & Africa Gammaretroviral Vector Sales Growth
5 Americas
5.1 Americas Gammaretroviral Vector Sales by Country
5.1.1 Americas Gammaretroviral Vector Sales by Country (2017-2022)
5.1.2 Americas Gammaretroviral Vector Revenue by Country (2017-2022)
5.2 Americas Gammaretroviral Vector Sales by Type
5.3 Americas Gammaretroviral Vector Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gammaretroviral Vector Sales by Region
6.1.1 APAC Gammaretroviral Vector Sales by Region (2017-2022)
6.1.2 APAC Gammaretroviral Vector Revenue by Region (2017-2022)
6.2 APAC Gammaretroviral Vector Sales by Type
6.3 APAC Gammaretroviral Vector Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gammaretroviral Vector by Country
7.1.1 Europe Gammaretroviral Vector Sales by Country (2017-2022)
7.1.2 Europe Gammaretroviral Vector Revenue by Country (2017-2022)
7.2 Europe Gammaretroviral Vector Sales by Type
7.3 Europe Gammaretroviral Vector Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gammaretroviral Vector by Country
8.1.1 Middle East & Africa Gammaretroviral Vector Sales by Country (2017-2022)
8.1.2 Middle East & Africa Gammaretroviral Vector Revenue by Country (2017-2022)
8.2 Middle East & Africa Gammaretroviral Vector Sales by Type
8.3 Middle East & Africa Gammaretroviral Vector Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gammaretroviral Vector
10.3 Manufacturing Process Analysis of Gammaretroviral Vector
10.4 Industry Chain Structure of Gammaretroviral Vector
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gammaretroviral Vector Distributors
11.3 Gammaretroviral Vector Customer
12 World Forecast Review for Gammaretroviral Vector by Geographic Region
12.1 Global Gammaretroviral Vector Market Size Forecast by Region
12.1.1 Global Gammaretroviral Vector Forecast by Region (2023-2028)
12.1.2 Global Gammaretroviral Vector Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gammaretroviral Vector Forecast by Type
12.7 Global Gammaretroviral Vector Forecast by Application
13 Key Players Analysis
13.1 Novasep
13.1.1 Novasep Company Information
13.1.2 Novasep Gammaretroviral Vector Product Offered
13.1.3 Novasep Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novasep Main Business Overview
13.1.5 Novasep Latest Developments
13.2 MerckKGaA
13.2.1 MerckKGaA Company Information
13.2.2 MerckKGaA Gammaretroviral Vector Product Offered
13.2.3 MerckKGaA Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 MerckKGaA Main Business Overview
13.2.5 MerckKGaA Latest Developments
13.3 Charles River Laboratories
13.3.1 Charles River Laboratories Company Information
13.3.2 Charles River Laboratories Gammaretroviral Vector Product Offered
13.3.3 Charles River Laboratories Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Charles River Laboratories Main Business Overview
13.3.5 Charles River Laboratories Latest Developments
13.4 UniQure N.V.
13.4.1 UniQure N.V. Company Information
13.4.2 UniQure N.V. Gammaretroviral Vector Product Offered
13.4.3 UniQure N.V. Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 UniQure N.V. Main Business Overview
13.4.5 UniQure N.V. Latest Developments
13.5 Waisman Biomanufacturing
13.5.1 Waisman Biomanufacturing Company Information
13.5.2 Waisman Biomanufacturing Gammaretroviral Vector Product Offered
13.5.3 Waisman Biomanufacturing Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Waisman Biomanufacturing Main Business Overview
13.5.5 Waisman Biomanufacturing Latest Developments
13.6 Creative-Biogene
13.6.1 Creative-Biogene Company Information
13.6.2 Creative-Biogene Gammaretroviral Vector Product Offered
13.6.3 Creative-Biogene Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Creative-Biogene Main Business Overview
13.6.5 Creative-Biogene Latest Developments
13.7 Aldevron
13.7.1 Aldevron Company Information
13.7.2 Aldevron Gammaretroviral Vector Product Offered
13.7.3 Aldevron Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Aldevron Main Business Overview
13.7.5 Aldevron Latest Developments
13.8 Addgene
13.8.1 Addgene Company Information
13.8.2 Addgene Gammaretroviral Vector Product Offered
13.8.3 Addgene Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Addgene Main Business Overview
13.8.5 Addgene Latest Developments
13.9 Oxford Biomedica
13.9.1 Oxford Biomedica Company Information
13.9.2 Oxford Biomedica Gammaretroviral Vector Product Offered
13.9.3 Oxford Biomedica Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Oxford Biomedica Main Business Overview
13.9.5 Oxford Biomedica Latest Developments
13.10 Thermo Fisher Scientific Inc.
13.10.1 Thermo Fisher Scientific Inc. Company Information
13.10.2 Thermo Fisher Scientific Inc. Gammaretroviral Vector Product Offered
13.10.3 Thermo Fisher Scientific Inc. Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Thermo Fisher Scientific Inc. Main Business Overview
13.10.5 Thermo Fisher Scientific Inc. Latest Developments
13.11 Fujifilm Corporation
13.11.1 Fujifilm Corporation Company Information
13.11.2 Fujifilm Corporation Gammaretroviral Vector Product Offered
13.11.3 Fujifilm Corporation Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Fujifilm Corporation Main Business Overview
13.11.5 Fujifilm Corporation Latest Developments
13.12 Spark Therapeutics Inc
13.12.1 Spark Therapeutics Inc Company Information
13.12.2 Spark Therapeutics Inc Gammaretroviral Vector Product Offered
13.12.3 Spark Therapeutics Inc Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Spark Therapeutics Inc Main Business Overview
13.12.5 Spark Therapeutics Inc Latest Developments
13.13 ABL Inc
13.13.1 ABL Inc Company Information
13.13.2 ABL Inc Gammaretroviral Vector Product Offered
13.13.3 ABL Inc Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 ABL Inc Main Business Overview
13.13.5 ABL Inc Latest Developments
13.14 Boehringer Ingelheim International GmbH
13.14.1 Boehringer Ingelheim International GmbH Company Information
13.14.2 Boehringer Ingelheim International GmbH Gammaretroviral Vector Product Offered
13.14.3 Boehringer Ingelheim International GmbH Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Boehringer Ingelheim International GmbH Main Business Overview
13.14.5 Boehringer Ingelheim International GmbH Latest Developments
13.15 Brammer Bio
13.15.1 Brammer Bio Company Information
13.15.2 Brammer Bio Gammaretroviral Vector Product Offered
13.15.3 Brammer Bio Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Brammer Bio Main Business Overview
13.15.5 Brammer Bio Latest Developments
13.16 Creative Biogene
13.16.1 Creative Biogene Company Information
13.16.2 Creative Biogene Gammaretroviral Vector Product Offered
13.16.3 Creative Biogene Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Creative Biogene Main Business Overview
13.16.5 Creative Biogene Latest Developments
13.17 General Electric
13.17.1 General Electric Company Information
13.17.2 General Electric Gammaretroviral Vector Product Offered
13.17.3 General Electric Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 General Electric Main Business Overview
13.17.5 General Electric Latest Developments
13.18 Pfizer Inc
13.18.1 Pfizer Inc Company Information
13.18.2 Pfizer Inc Gammaretroviral Vector Product Offered
13.18.3 Pfizer Inc Gammaretroviral Vector Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Pfizer Inc Main Business Overview
13.18.5 Pfizer Inc Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Gammaretroviral Vector Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Gammaretroviral Vector Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Lentiviral Vectors
Table 4. Major Players of Adenoviral Vectors
Table 5. Major Players of Adeno-Associated Viral Vectors
Table 6. Major Players of Other
Table 7. Global Gammaretroviral Vector Sales by Type (2017-2022) & (K Units)
Table 8. Global Gammaretroviral Vector Sales Market Share by Type (2017-2022)
Table 9. Global Gammaretroviral Vector Revenue by Type (2017-2022) & ($ million)
Table 10. Global Gammaretroviral Vector Revenue Market Share by Type (2017-2022)
Table 11. Global Gammaretroviral Vector Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Gammaretroviral Vector Sales by Application (2017-2022) & (K Units)
Table 13. Global Gammaretroviral Vector Sales Market Share by Application (2017-2022)
Table 14. Global Gammaretroviral Vector Revenue by Application (2017-2022)
Table 15. Global Gammaretroviral Vector Revenue Market Share by Application (2017-2022)
Table 16. Global Gammaretroviral Vector Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Gammaretroviral Vector Sales by Company (2020-2022) & (K Units)
Table 18. Global Gammaretroviral Vector Sales Market Share by Company (2020-2022)
Table 19. Global Gammaretroviral Vector Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Gammaretroviral Vector Revenue Market Share by Company (2020-2022)
Table 21. Global Gammaretroviral Vector Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Gammaretroviral Vector Producing Area Distribution and Sales Area
Table 23. Players Gammaretroviral Vector Products Offered
Table 24. Gammaretroviral Vector Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Gammaretroviral Vector Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Gammaretroviral Vector Sales Market Share Geographic Region (2017-2022)
Table 29. Global Gammaretroviral Vector Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Gammaretroviral Vector Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Gammaretroviral Vector Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Gammaretroviral Vector Sales Market Share by Country/Region (2017-2022)
Table 33. Global Gammaretroviral Vector Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Gammaretroviral Vector Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Gammaretroviral Vector Sales by Country (2017-2022) & (K Units)
Table 36. Americas Gammaretroviral Vector Sales Market Share by Country (2017-2022)
Table 37. Americas Gammaretroviral Vector Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Gammaretroviral Vector Revenue Market Share by Country (2017-2022)
Table 39. Americas Gammaretroviral Vector Sales by Type (2017-2022) & (K Units)
Table 40. Americas Gammaretroviral Vector Sales Market Share by Type (2017-2022)
Table 41. Americas Gammaretroviral Vector Sales by Application (2017-2022) & (K Units)
Table 42. Americas Gammaretroviral Vector Sales Market Share by Application (2017-2022)
Table 43. APAC Gammaretroviral Vector Sales by Region (2017-2022) & (K Units)
Table 44. APAC Gammaretroviral Vector Sales Market Share by Region (2017-2022)
Table 45. APAC Gammaretroviral Vector Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Gammaretroviral Vector Revenue Market Share by Region (2017-2022)
Table 47. APAC Gammaretroviral Vector Sales by Type (2017-2022) & (K Units)
Table 48. APAC Gammaretroviral Vector Sales Market Share by Type (2017-2022)
Table 49. APAC Gammaretroviral Vector Sales by Application (2017-2022) & (K Units)
Table 50. APAC Gammaretroviral Vector Sales Market Share by Application (2017-2022)
Table 51. Europe Gammaretroviral Vector Sales by Country (2017-2022) & (K Units)
Table 52. Europe Gammaretroviral Vector Sales Market Share by Country (2017-2022)
Table 53. Europe Gammaretroviral Vector Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Gammaretroviral Vector Revenue Market Share by Country (2017-2022)
Table 55. Europe Gammaretroviral Vector Sales by Type (2017-2022) & (K Units)
Table 56. Europe Gammaretroviral Vector Sales Market Share by Type (2017-2022)
Table 57. Europe Gammaretroviral Vector Sales by Application (2017-2022) & (K Units)
Table 58. Europe Gammaretroviral Vector Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Gammaretroviral Vector Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Gammaretroviral Vector Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Gammaretroviral Vector Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Gammaretroviral Vector Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Gammaretroviral Vector Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Gammaretroviral Vector Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Gammaretroviral Vector Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Gammaretroviral Vector Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Gammaretroviral Vector
Table 68. Key Market Challenges & Risks of Gammaretroviral Vector
Table 69. Key Industry Trends of Gammaretroviral Vector
Table 70. Gammaretroviral Vector Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Gammaretroviral Vector Distributors List
Table 73. Gammaretroviral Vector Customer List
Table 74. Global Gammaretroviral Vector Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Gammaretroviral Vector Sales Market Forecast by Region
Table 76. Global Gammaretroviral Vector Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Gammaretroviral Vector Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Gammaretroviral Vector Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Gammaretroviral Vector Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Gammaretroviral Vector Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Gammaretroviral Vector Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Gammaretroviral Vector Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Gammaretroviral Vector Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Gammaretroviral Vector Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Gammaretroviral Vector Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Gammaretroviral Vector Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Gammaretroviral Vector Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Gammaretroviral Vector Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Gammaretroviral Vector Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Gammaretroviral Vector Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Gammaretroviral Vector Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Gammaretroviral Vector Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Gammaretroviral Vector Revenue Market Share Forecast by Application (2023-2028)
Table 94. Novasep Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 95. Novasep Gammaretroviral Vector Product Offered
Table 96. Novasep Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Novasep Main Business
Table 98. Novasep Latest Developments
Table 99. MerckKGaA Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 100. MerckKGaA Gammaretroviral Vector Product Offered
Table 101. MerckKGaA Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. MerckKGaA Main Business
Table 103. MerckKGaA Latest Developments
Table 104. Charles River Laboratories Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 105. Charles River Laboratories Gammaretroviral Vector Product Offered
Table 106. Charles River Laboratories Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Charles River Laboratories Main Business
Table 108. Charles River Laboratories Latest Developments
Table 109. UniQure N.V. Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 110. UniQure N.V. Gammaretroviral Vector Product Offered
Table 111. UniQure N.V. Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. UniQure N.V. Main Business
Table 113. UniQure N.V. Latest Developments
Table 114. Waisman Biomanufacturing Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 115. Waisman Biomanufacturing Gammaretroviral Vector Product Offered
Table 116. Waisman Biomanufacturing Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Waisman Biomanufacturing Main Business
Table 118. Waisman Biomanufacturing Latest Developments
Table 119. Creative-Biogene Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 120. Creative-Biogene Gammaretroviral Vector Product Offered
Table 121. Creative-Biogene Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Creative-Biogene Main Business
Table 123. Creative-Biogene Latest Developments
Table 124. Aldevron Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 125. Aldevron Gammaretroviral Vector Product Offered
Table 126. Aldevron Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Aldevron Main Business
Table 128. Aldevron Latest Developments
Table 129. Addgene Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 130. Addgene Gammaretroviral Vector Product Offered
Table 131. Addgene Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Addgene Main Business
Table 133. Addgene Latest Developments
Table 134. Oxford Biomedica Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 135. Oxford Biomedica Gammaretroviral Vector Product Offered
Table 136. Oxford Biomedica Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Oxford Biomedica Main Business
Table 138. Oxford Biomedica Latest Developments
Table 139. Thermo Fisher Scientific Inc. Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 140. Thermo Fisher Scientific Inc. Gammaretroviral Vector Product Offered
Table 141. Thermo Fisher Scientific Inc. Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Thermo Fisher Scientific Inc. Main Business
Table 143. Thermo Fisher Scientific Inc. Latest Developments
Table 144. Fujifilm Corporation Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 145. Fujifilm Corporation Gammaretroviral Vector Product Offered
Table 146. Fujifilm Corporation Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Fujifilm Corporation Main Business
Table 148. Fujifilm Corporation Latest Developments
Table 149. Spark Therapeutics Inc Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 150. Spark Therapeutics Inc Gammaretroviral Vector Product Offered
Table 151. Spark Therapeutics Inc Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Spark Therapeutics Inc Main Business
Table 153. Spark Therapeutics Inc Latest Developments
Table 154. ABL Inc Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 155. ABL Inc Gammaretroviral Vector Product Offered
Table 156. ABL Inc Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. ABL Inc Main Business
Table 158. ABL Inc Latest Developments
Table 159. Boehringer Ingelheim International GmbH Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 160. Boehringer Ingelheim International GmbH Gammaretroviral Vector Product Offered
Table 161. Boehringer Ingelheim International GmbH Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. Boehringer Ingelheim International GmbH Main Business
Table 163. Boehringer Ingelheim International GmbH Latest Developments
Table 164. Brammer Bio Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 165. Brammer Bio Gammaretroviral Vector Product Offered
Table 166. Brammer Bio Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 167. Brammer Bio Main Business
Table 168. Brammer Bio Latest Developments
Table 169. Creative Biogene Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 170. Creative Biogene Gammaretroviral Vector Product Offered
Table 171. Creative Biogene Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 172. Creative Biogene Main Business
Table 173. Creative Biogene Latest Developments
Table 174. General Electric Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 175. General Electric Gammaretroviral Vector Product Offered
Table 176. General Electric Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 177. General Electric Main Business
Table 178. General Electric Latest Developments
Table 179. Pfizer Inc Basic Information, Gammaretroviral Vector Manufacturing Base, Sales Area and Its Competitors
Table 180. Pfizer Inc Gammaretroviral Vector Product Offered
Table 181. Pfizer Inc Gammaretroviral Vector Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 182. Pfizer Inc Main Business
Table 183. Pfizer Inc Latest Developments
List of Figures
Figure 1. Picture of Gammaretroviral Vector
Figure 2. Gammaretroviral Vector Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gammaretroviral Vector Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Gammaretroviral Vector Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Gammaretroviral Vector Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Lentiviral Vectors
Figure 10. Product Picture of Adenoviral Vectors
Figure 11. Product Picture of Adeno-Associated Viral Vectors
Figure 12. Product Picture of Other
Figure 13. Global Gammaretroviral Vector Sales Market Share by Type in 2021
Figure 14. Global Gammaretroviral Vector Revenue Market Share by Type (2017-2022)
Figure 15. Gammaretroviral Vector Consumed in Gene Therapy
Figure 16. Global Gammaretroviral Vector Market: Gene Therapy (2017-2022) & (K Units)
Figure 17. Gammaretroviral Vector Consumed in Vaccinology
Figure 18. Global Gammaretroviral Vector Market: Vaccinology (2017-2022) & (K Units)
Figure 19. Gammaretroviral Vector Consumed in Other
Figure 20. Global Gammaretroviral Vector Market: Other (2017-2022) & (K Units)
Figure 21. Global Gammaretroviral Vector Sales Market Share by Application (2017-2022)
Figure 22. Global Gammaretroviral Vector Revenue Market Share by Application in 2021
Figure 23. Gammaretroviral Vector Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Gammaretroviral Vector Revenue Market Share by Company in 2021
Figure 25. Global Gammaretroviral Vector Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Gammaretroviral Vector Revenue Market Share by Geographic Region in 2021
Figure 27. Global Gammaretroviral Vector Sales Market Share by Region (2017-2022)
Figure 28. Global Gammaretroviral Vector Revenue Market Share by Country/Region in 2021
Figure 29. Americas Gammaretroviral Vector Sales 2017-2022 (K Units)
Figure 30. Americas Gammaretroviral Vector Revenue 2017-2022 ($ Millions)
Figure 31. APAC Gammaretroviral Vector Sales 2017-2022 (K Units)
Figure 32. APAC Gammaretroviral Vector Revenue 2017-2022 ($ Millions)
Figure 33. Europe Gammaretroviral Vector Sales 2017-2022 (K Units)
Figure 34. Europe Gammaretroviral Vector Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Gammaretroviral Vector Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Gammaretroviral Vector Revenue 2017-2022 ($ Millions)
Figure 37. Americas Gammaretroviral Vector Sales Market Share by Country in 2021
Figure 38. Americas Gammaretroviral Vector Revenue Market Share by Country in 2021
Figure 39. United States Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Gammaretroviral Vector Sales Market Share by Region in 2021
Figure 44. APAC Gammaretroviral Vector Revenue Market Share by Regions in 2021
Figure 45. China Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Gammaretroviral Vector Sales Market Share by Country in 2021
Figure 52. Europe Gammaretroviral Vector Revenue Market Share by Country in 2021
Figure 53. Germany Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Gammaretroviral Vector Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Gammaretroviral Vector Revenue Market Share by Country in 2021
Figure 60. Egypt Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Gammaretroviral Vector Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Gammaretroviral Vector in 2021
Figure 66. Manufacturing Process Analysis of Gammaretroviral Vector
Figure 67. Industry Chain Structure of Gammaretroviral Vector
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets